Intellia Therapeutics, Inc. (NTLA)
11.88
-0.14
(-1.12%)
USD |
NASDAQ |
Jan 15, 16:00
12.00
+0.12
(+0.97%)
After-Hours: 20:00
Intellia Therapeutics SG&A Expense (TTM): 119.17M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Beam Therapeutics, Inc. | 110.20M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Pacific Biosciences of California, Inc. | 149.08M |
| Twist Bioscience Corp. | 246.98M |